Could a smaller antibiotic dose beat gonorrhea just as well?

NCT ID NCT07710118

Recruiting now Disease control Sponsor: National Taiwan University Hospital Source: ClinicalTrials.gov ↗

First seen Jul 17, 2026 · Last updated Jul 17, 2026

Summary

This study compares two doses of the antibiotic ceftriaxone—500 mg versus 1000 mg—given as a single shot to treat uncomplicated gonorrhea. Researchers want to see if the lower dose works just as well, which could mean fewer side effects and less antibiotic use. The trial involves 400 men aged 18 and older with confirmed gonorrhea infection.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: ceftriaxone, an antibiotic given as a single injection
What this could lead to: If successful, a lower dose could reduce antibiotic use and side effects while still effectively treating gonorrhea.
What could go wrong: This is a single trial with 400 participants, and the lower dose might prove less effective, potentially leading to treatment failure or resistance.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates